Bedtime administration of long-acting antihypertensive drugs restores normal nocturnal blood pressure fall in nondippers with essential hypertension

  • Atsushi Takeda
  • Takayuki Toda
  • Takuma Fujii
  • Noriaki Matsui
Original Article



Nondipper hypertensive patients have more pronounced target organ injury. We examined whether shifting the time of dosing long-acting antihypertensive drugs from morning to bedtime reduces nocturnal blood pressure (BP) and restores normal nocturnal dipping in nondippers with essential hypertension.


We studied 71 Japanese hypertensive patients who received long-acting antihypertensive drugs once daily in the morning using 24-h ambulatory BP monitoring. After determination of circadian BP pattern, medication time was changed to bedtime only in nondippers.


Among 71 patients, 36 were classified as dippers and 35 as nondippers. After shifting administration time from morning to bedtime in 34 nondippers, the office and 24-h ambulatory BP did not change, but the diurnal BP slightly increased and nocturnal BP markedly decreased. The percentages of nocturnal decline in systolic and diastolic BP increased from 2.6% to 15.5% (P < 0.0001) and 5.6% to 16.9% (P < 0.0001). Morning BP at 7 a.m.–11 a.m. did not increase by bedtime administration. The frequency of dippers increased from 0/34 (0%) to 24/34 (71%). Adding to 50% of dippers on morning administration, 86% of the hypertensive patients became dippers by deciding the medication time according to dipper status.


Nondippers on morning dosing can be changed to dippers by shifting administration time to bedtime, reducing nocturnal BP but not changing office BP, 24-h ambulatory BP or morning BP. In treating essential hypertensive patients, it is desirable to measure 24-h ambulatory BP as well as office BP and to decide the administration time of long-acting antihypertensive drugs to normalize nocturnal BP fall.


Antihypertensive drugs Hypertension Dipper Circadian rhythm Blood pressure monitoring 


  1. 1.
    Staessen JA, Wang JG, Thijs L. Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet. 2001;358:1305–15.PubMedCrossRefGoogle Scholar
  2. 2.
    Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–13.CrossRefGoogle Scholar
  3. 3.
    Kario K, Pickering TG, Umeda Y, Hoshide S, Hoshide Y, Morinari M, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation. 2003;107:1401–6.PubMedCrossRefGoogle Scholar
  4. 4.
    Gosse P, Lasserre R, Minifie C, Lemetayer P, Clementy J. Blood pressure surge on rising. J Hypertens. 2004;22:1113–8.PubMedCrossRefGoogle Scholar
  5. 5.
    Muller JE, Ludmer PL, Willich SN, Tofler GH, Aylmer G, Klangos I, et al. Circadian variation in the frequency of sudden cardiac death. Circulation. 1987;75:131–8.PubMedGoogle Scholar
  6. 6.
    Amar J, Vernier I, Rossignol E, Bongard V, Arnaud C, Conte JJ, et al. Nocturnal blood pressure and 24-hour pulse pressure are potent indicators of mortality in hemodialysis patients. Kidney Int. 2000;57:2485–91.PubMedCrossRefGoogle Scholar
  7. 7.
    Lurbe E, Redon J, Kesani A, Pascual JM, Tacons J, Alvarez V, et al. Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med. 2002;347:797–805.PubMedCrossRefGoogle Scholar
  8. 8.
    Staessen JA, Thijs L, Fagard R, O’Brien ET, Clement D, de Leeuw PW, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic hypertension in Europe trial investigators. JAMA. 1999;282:539–46.PubMedCrossRefGoogle Scholar
  9. 9.
    Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, et al. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens. 2002;20:2183–9.PubMedCrossRefGoogle Scholar
  10. 10.
    Deakin M, Glenny HP, Ramage JK, Mills JG, Burland WL, Williams JG. Large single daily dose of histamine H2 receptor antagonist for duodenal ulcer. How much and when? A clinical pharmacological study. Gut. 1987;28:566–72.PubMedCrossRefGoogle Scholar
  11. 11.
    Reinberg A, Pauchet F, Ruff F, Gervais A, Smolensky MH, Levi F, et al. Comparison of once-daily evening versus morning sustained-release theophylline dosing for nocturnal asthma. Chronobiol Int. 1987;4:409–19.PubMedCrossRefGoogle Scholar
  12. 12.
    Saito Y, Yoshida S, Nakaya N, Hata Y, Goto Y. Comparison between morning and evening doses of simvastatin in hyperlipidemic subjects. A double-blind comparative study. Arterioscler Thromb. 1991;11:816–26.PubMedGoogle Scholar
  13. 13.
    Koren G, Ferrazzini G, Sohl H, Robieux I, Johnson D, Giesbrecht E. Chronopharmacology of methotrexate pharmacokinetics in childhood leukemia. Chronobiol Int. 1992;9:434–8.PubMedCrossRefGoogle Scholar
  14. 14.
    Pickering TG, Shimbo D, Haas D. Ambulatory blood-pressure monitoring. N Engl J Med. 2006;354:2368–74.PubMedCrossRefGoogle Scholar
  15. 15.
    O’Brien E, Sheridan J, O’Malley K. Dippers and non-dippers. Lancet. 2006;2(8607):397.Google Scholar
  16. 16.
    Covic A, Goldsmith DJ. Ambulatory blood pressure measurement in the renal patient. Curr Hypertens Rep. 2002;4:369–76.PubMedCrossRefGoogle Scholar
  17. 17.
    White WB, Mansoor GA, Pickering TG, Vidt DG, Hutchinson HG, Johnson RB, et al. Differential effects of morning and evening dosing of nisoldipine ER on circadian blood pressure and heart rate. Am J Hypertens. 1999;12:806–14.PubMedCrossRefGoogle Scholar
  18. 18.
    Portaluppi F, Vergnani L, Manfredini R, degli Uberti EC, Fersini C. Time-dependent effect of isradipine on the nocturnal hypertension in chronic renal failure. Am J Hypertens. 1995;8:719–26.PubMedCrossRefGoogle Scholar
  19. 19.
    Hermida RC, Calvo C, Ayala DE, Fernandez JR, Covelo M, Mojon A, et al. Treatment of non-dipper hypertension with bedtime administration of valsartan. J Hypertens. 2005;23:1913–22.PubMedCrossRefGoogle Scholar
  20. 20.
    Morgan T, Anderson A, Jones E. The effect on 24 h blood pressure control of an angiotensin converting enzyme inhibitor (perindopril) administered in the morning or at night. J Hypertens. 1997;15:205–11.PubMedCrossRefGoogle Scholar
  21. 21.
    Hermida RC, Calvo C, Ayala DE, Dominguez MJ, Covelo M, Fernandez JR, et al. Administration time-dependent effects of valsartan on ambulatory blood pressure in hypertensive subjects. Hypertension. 2003;42:283–90.PubMedCrossRefGoogle Scholar
  22. 22.
    Hermida RC, Calvo C, Ayala DE, Dominguez MJ, Covelo M, Fernandez JR, et al. Administration-time-dependent effects of doxazosin GITS on ambulatory blood pressure of hypertensive subjects. Chronobiol Int. 2004;21:277–96.PubMedCrossRefGoogle Scholar
  23. 23.
    Brandenberger G, Follenius M, Goichot B, Saini J, Spiegel K, Ehrhart J, et al. Twenty-four-hour profiles of plasma renin activity in relation to the sleep–wake cycle. J Hypertens. 1994;12:277–83.PubMedCrossRefGoogle Scholar
  24. 24.
    Linsell CR, Lightman SL, Mullen PE, Brown MJ, Causon RC. Circadian rhythms of epinephrine and norepinephrine in man. J Clin Endocrinol Metab. 1985;60:1210–5.PubMedCrossRefGoogle Scholar
  25. 25.
    Kario K, Matsuo T, Kobayashi H, Imiya M, Matsuo M, Shimada K. Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients. Advanced silent cerebrovascular damage in extreme dippers. Hypertension. 1996;27:130–5.PubMedGoogle Scholar
  26. 26.
    Kario K, Shimada K. Differential effects of amlodipine on ambulatory blood pressure in elderly hypertensive patients with different nocturnal reductions in blood pressure. Am J Hypertens. 1997;10:261–8.PubMedCrossRefGoogle Scholar
  27. 27.
    Musso NR, Lotti G. Reproducibility of ambulatory blood pressure monitoring. Blood Press Monit. 1996;1:105–9.PubMedGoogle Scholar
  28. 28.
    The Scientific Committee. Consensus document on non-invasive ambulatory blood pressure monitoring. J Hypertens. 1990;8(Suppl 6):S135–40.Google Scholar
  29. 29.
    Van Ittersum FJ, Ijzerman RG, Stehouwer CD, Donker AJ. Analysis of twenty-four-hour ambulatory blood pressure monitoring: what time period to assess blood pressures during waking and sleeping? J Hypertens. 1995;13:1053–8.PubMedCrossRefGoogle Scholar
  30. 30.
    Boggia J, Li Y, Thijs L, Hansen TW, Kikuya M, Björklund-Bodegård K, et al. International database on ambulatory blood pressure monitoring in relation to cardiovascular outcomes (IDACO) investigators: prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet. 2007;370:1219–29.PubMedCrossRefGoogle Scholar

Copyright information

© Japanese Society of Nephrology 2009

Authors and Affiliations

  • Atsushi Takeda
    • 1
    • 2
  • Takayuki Toda
    • 1
  • Takuma Fujii
    • 1
  • Noriaki Matsui
    • 1
  1. 1.Kidney CenterTsuchiura Kyodo General HospitalIbarakiJapan
  2. 2.Midorino ClinicBandoJapan

Personalised recommendations